Fig. 1From: The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision makingHistogram depicting stated indications for use of neoadjuvant chemotherapy and endocrine therapy. If selecting “Other” then respondents were invited to provide a free text response. Other responses were “downstaging of heavy nodal disease”, “HER2+ve disease ≥2 cm in diameter”, and “to allow patients time to prepare psychologically for mastectomy/reconstruction”Back to article page